Progress in the Diagnosis, Prevention, and Treatment of Pertussis
- PMID: 12760818
- DOI: 10.1007/s11908-003-0076-9
Progress in the Diagnosis, Prevention, and Treatment of Pertussis
Abstract
Pertussis ("whooping cough"), caused by the gram- negative pleomorphic bacillus Bordetella pertussis, is a highly contagious, potentially life-threatening respiratory tract illness that has re-emerged worldwide as a cause of substantial morbidity and mortality in infants, children, and adolescents, even in countries with high vaccination rates. Waning immunity after immunization during childhood has been associated with a growing pool of susceptible adolescents and adults who are capable of transmitting pertussis to vulnerable unvaccinated or incompletely vaccinated infants. The use of acellular pertussis vaccine boosters in adolescents has been proposed and is likely to be recommended. Active immunization and improved methods for early diagnosis are key in the management of pertussis, and represent the most rapidly evolving aspects of this disease.
Similar articles
-
Pertussis in infants, children, and adolescents: diagnosis, treatment, and prevention.Semin Pediatr Infect Dis. 2006 Jan;17(1):14-9. doi: 10.1053/j.spid.2005.11.005. Semin Pediatr Infect Dis. 2006. PMID: 16522501 Review.
-
Acellular pertussis vaccine use in risk groups (adolescents, pregnant women, newborns and health care workers): a review of evidences and recommendations.Vaccine. 2012 Jul 27;30(35):5179-90. doi: 10.1016/j.vaccine.2012.06.005. Epub 2012 Jun 15. Vaccine. 2012. PMID: 22709953 Review.
-
Acellular pertussis vaccine effectiveness and waning immunity in Alberta, Canada: 2010-2015, a Canadian Immunization Research Network (CIRN) study.Vaccine. 2019 Jul 9;37(30):4140-4146. doi: 10.1016/j.vaccine.2019.05.067. Epub 2019 Jun 1. Vaccine. 2019. PMID: 31164304
-
Re-emergence of pertussis: what are the solutions?Expert Rev Vaccines. 2012 Nov;11(11):1331-46. doi: 10.1586/erv.12.118. Expert Rev Vaccines. 2012. PMID: 23249233 Review.
-
Bordetella Pertussis infections in vaccinated and unvaccinated adolescents and adults, as assessed in a national prospective randomized Acellular Pertussis Vaccine Trial (APERT).Clin Infect Dis. 2006 Jul 15;43(2):151-7. doi: 10.1086/504803. Epub 2006 Jun 5. Clin Infect Dis. 2006. PMID: 16779740 Clinical Trial.
Cited by
-
Incidence and Burden of Pertussis Among Infants Less Than 1 Year of Age.Pediatr Infect Dis J. 2017 Mar;36(3):e54-e61. doi: 10.1097/INF.0000000000001440. Pediatr Infect Dis J. 2017. PMID: 27902648 Free PMC article.
-
The disease burden of pertussis in adults 50 years old and older in the United States: a retrospective study.BMC Infect Dis. 2013 Jan 23;13:32. doi: 10.1186/1471-2334-13-32. BMC Infect Dis. 2013. PMID: 23343438 Free PMC article.
-
The estimated incidence of pertussis in people aged 50 years old in the United States, 2006-2010.BMC Infect Dis. 2015 Nov 19;15:534. doi: 10.1186/s12879-015-1269-1. BMC Infect Dis. 2015. PMID: 26584525 Free PMC article.
References
LinkOut - more resources
Full Text Sources